Asheville, North Carolina. April 29, 2020
Genova Diagnostics introduced a COVID-19 test this week under the FDA Emergency Use Authorization (EUA). This testing will help support local NC hospitals and larger medical systems, as well as select institutions across the United States. Genova is currently performing its COVID-19 testing at their Asheville, NC laboratory and working to increase capacity of testing.
About the Genova Diagnostics Test
The Genova Diagnostics Test is a multiplex real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2. This is one of the most comprehensive tests to gain EUA status targeting three genes (ORF1ab, N gene and S gene). Testing utilizes a nasopharyngeal swab collection. Turnaround time is 48 hours. Price per test is $100.
At this time, we are unable to accommodate individual clinician orders. Hospitals and other healthcare institutions interested in utilizing the testing may contact us at 800-522-4762.
Media inquiries may email PR@gdx.net.
See other ways to reach us below the form.